ClinicalTrials.Veeva

Menu

Evaluation of the Prognostic Value of T7 and T12 Slices on Mortality in Resuscitation Patients With ARDS Caused by SARS-COV2 Infection (MUSCOV)

U

University Hospital Center (CHU) Dijon Bourgogne

Status

Not yet enrolling

Conditions

Acute Respiratory Distress Syndrom (SARS-Cov 2)

Treatments

Other: analysis of thoracic scans
Other: Data collection

Study type

Observational

Funder types

Other

Identifiers

NCT05594550
NGUYEN 2022

Details and patient eligibility

About

Sarcopenia is a risk factor for adverse outcome in critically ill patients. Sarcopenia might be estimated from muscle surface measure on tomodensitometry.

The purpose of the study is to identify if muscle surfaces measured on thoracic tomodensitometry are associated with mortality in patients with acute respiratory distress syndrome due to SARS-Cov-2.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients hospitalized in intensive care for SARS-Cov-2 infection since january 2020
  • Thoracic TDM within the 30 day preceding ICU admission and up to 24 hours after ICU admission

Exclusion criteria

  • Pregnancy
  • Neuromuscular disease

Trial design

200 participants in 2 patient groups

28-day survival
Description:
Alive 28 days after intensive care admission
Treatment:
Other: Data collection
Other: analysis of thoracic scans
28-day death
Description:
Deceased 28 days after intensive care admission
Treatment:
Other: Data collection
Other: analysis of thoracic scans

Trial contacts and locations

0

Loading...

Central trial contact

Maxime NGUYEN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems